David Brindley, a SENS Research Foundation-funded PhD candidate at the University of Oxford, is the lead author on a new publication in the journal BioProcess International discussing the automation of cell therapy biomanufacturing.
Rescue Assist, Inc., a company developing a robotic product that readily maneuvers through debris and will help rescue workers find disaster survivors, has pledged 7% of its profits to SENS Research Foundation.
SENS Research Foundation is delighted to welcome Dr. George Church, Professor of Genetics at Harvard Medical School, to our Research Advisory Board. Our RAB plays a key role in our mission to change the way the world researches and treats age-related disease. By applying expertise from multiple relevant areas, the Board assures that efforts and resources are directed along the most promising avenues.
SENS Research Foundation has established a new research center at Cambridge University and a collaboration with scientists at Yale University. The mission: develop new therapies to repair a critical form of molecular damage that drives the slow stiffening of the arteries with age. Such rejuvenation biotechnologies could prevent such deadly and disabling diseases of aging as stroke and kidney disease.